Portage Biotech
PRTG
#10137
Rank
€11.53 M
Marketcap
Country
5,06 €
Share price
5.33%
Change (1 day)
84.90%
Change (1 year)
Categories
Portage Biotech (PRTG) - Total liabilities
Total liabilities on the balance sheet as of September 2024 : €1.71 Million
According to Portage Biotech's latest financial reports the company's total liabilities are €1.71 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Portage Biotech - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-03-31 | €4.12 M | -81.13% |
| 2023-03-31 | €21.84 M | -17.23% |
| 2022-03-31 | €26.39 M | 13.58% |
| 2021-03-31 | €23.24 M | -6.93% |
| 2020-03-31 | €24.96 M | 11.4% |
| 2019-03-31 | €22.41 M | 7088.03% |
| 2018-03-31 | €0.31 M | 7.59% |
| 2017-03-31 | €0.28 M | 10.03% |
| 2016-03-31 | €0.26 M | -54.42% |
| 2015-03-31 | €0.57 M | 314.68% |
| 2014-03-31 | €0.13 M | -60.06% |
| 2013-03-31 | €0.34 M | -82.51% |
| 2012-03-31 | €1.99 M | 313.77% |
| 2011-03-31 | €0.48 M | -81.31% |
| 2010-03-31 | €2.58 M | 2737.95% |
| 2009-03-31 | €0.09 M | 150.48% |
| 2008-03-31 | €0.03 M | 15.29% |
| 2007-03-31 | €0.03 M | -73.34% |
| 2006-03-31 | €0.11 M | 48.37% |
| 2005-03-31 | €0.07 M | -85.1% |
| 2004-03-31 | €0.53 M | 147.4% |
| 2003-03-31 | €0.21 M | 49.01% |
| 2002-03-31 | €0.14 M | 34.16% |
| 2001-03-31 | €0.1 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 NRC Health
NRC | €90.03 M | 5,146.30% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | €2.68 M | 56.54% | Bahamas |